Conservative surgery vs. duodeneopancreatectomy in primary duodenal gastrointestinal stromal tumors (GIST): A retrospective review of 114 patients from the French Sarcoma Group (FSG)
- 1 October 2014
- journal article
- research article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 40 (10) , 1369-1375
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Clinical, Pathological and Surgical Characteristics of Duodenal Gastrointestinal Stromal Tumor and Their Influence on Survival: A Multi-Center StudyAnnals of Surgical Oncology, 2012
- One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal TumorJAMA, 2012
- Clinicopathological and Immunohistochemical Features of Gastointestinal Stromal TumorsCancer Research and Treatment, 2010
- Surgery for Gastrointestinal Stromal Tumors of the DuodenumAnnals of Surgical Oncology, 2009
- Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST)European Journal of Surgical Oncology, 2009
- Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trialThe Lancet, 2009
- Risk Criteria and Prognostic Factors for Predicting Recurrences After Resection of Primary Gastrointestinal Stromal TumorAnnals of Surgical Oncology, 2007
- Local excision of duodenal gastrointestinal stromal tumorJournal of Surgical Oncology, 2007
- Combined Surgical and Molecular TherapyAnnals of Surgery, 2006
- Classification of Surgical ComplicationsAnnals of Surgery, 2004